Provides reimbursement for transportation to and from inpatient and outpatient diagnosis and treatment of substance use disorder.
Summary
Bill A03120 amends the New York insurance law to require that all health insurance policies providing hospital and medical coverage include reimbursement for transportation to and from inpatient and outpatient treatment for substance use disorder. This includes coverage for detoxification and rehabilitation services, ensuring that such treatment is accessible to individuals seeking help. The bill mandates that insurance policies cannot impose more restrictive financial requirements or treatment limitations on substance use disorder benefits compared to other medical and surgical benefits.
Impact
If enacted, this bill will enhance access to substance use disorder treatment by ensuring that transportation costs are covered by insurance policies. It will amend existing laws to provide comprehensive coverage for both inpatient and outpatient services related to substance use disorder, thereby aligning the treatment of substance use disorders with other medical conditions in terms of insurance coverage. This change is expected to reduce barriers for individuals seeking necessary treatment.
Sentiment
The general sentiment surrounding Bill A03120 appears to be supportive, as it aims to address the critical issue of accessibility to substance use disorder treatment. Discussions in committee and among stakeholders indicate a recognition of the importance of comprehensive coverage for mental health and substance use disorders, although specific voting history and detailed committee discussions are not available at this time.
Contention
Notable points of contention may arise around the potential financial implications for insurance providers, as mandating coverage for transportation could increase operational costs. Some stakeholders may argue about the balance between ensuring access to treatment and the financial burden on insurers. However, specific opposing viewpoints or concerns have not been documented in the available committee discussions or voting history.
Increases Medicaid reimbursement for in-person partial care and intensive outpatient behavioral health and substance use disorder treatment services, and associated transportation services, for adults.
Increases Medicaid reimbursement for in-person partial care and intensive outpatient behavioral health and substance use disorder treatment services, and associated transportation services, for adults.
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.
Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.